Latest Announcements

Ind-Swift Laboratories Limited reported strong Q1 FY27 results with operating EBITDA up 2.85x YoY to ₹33.32 crore and PAT up 2.04x YoY to ₹24.68 crore, driven by growing international operations and expansion across regulated and emerging markets.

Eureka Forbes Ltd announced its Q1 FY27 financial results, with revenue growth of 15.3% YoY, highest ever, and reported PAT growth of 43.9% YoY.

Eureka Forbes Ltd announced its financial results for Q1 FY27, with revenue growth of 15.3% YoY, highest ever, and reported PAT grew by 43.9% YoY.

Gujarat Fluorochemicals Ltd has announced its Q1FY27 investor presentation, highlighting a 23% YoY increase in chemical segment revenue, 29% YoY increase in EBITDA, and 33% YoY increase in PAT. The company also provided an update on its business verticals, including battery materials, fluoropolymers, and fluorochemicals.

Eureka Forbes Limited announced its financial results for Q1 FY27, with revenue growth of 15.3% YoY, the highest ever, and reported PAT growth of 43.9% YoY. The company attributed the growth to double-digit volume growth and price increases in Water Purifiers and strong growth in Emerging Categories. Adjusted EBITDA margins moderated by 46bps YoY to 10.5%, and Adjusted PBT grew by 7.2% YoY to Rs 61.5 Cr.

Lakshmi Finance & Industrial Corporation Limited has submitted its unaudited financial results for the quarter ended June 30, 2026. The company reported a net profit of Rs. 404.35 lakhs, with earnings per equity share of Rs. 13.48. The results were reviewed by the Audit Committee and approved by the Board on August 12, 2026.

B. L. Kashyap and Sons Limited has informed the Exchange about Investor Presentation, enclosing unaudited financial results for the quarter ended June 30, 2026, and highlighting key investment highlights, financial performance, strategic priorities, and ongoing projects.

Gujarat Fluorochemicals Limited has informed the Exchange about Investor Presentation for Q1FY27, with revenue up by 24% YoY, EBITDA up by 24% YoY, and PAT up by 20% YoY. The company has also provided an overview of its business verticals, including Battery Materials, Fluoropolymers, and Fluorochemicals, with a strong outlook for growth and expansion.

Eureka Forbes Limited has announced its financial results for the quarter ended June 30, 2026, with revenue growth of 15.3% YoY, the highest ever in the company's transformation journey, driven by double-digit volume growth and price increases in Water Purifiers and strong growth in Emerging Categories.

Bata India Limited has submitted an Investor Presentation for Q1 FY27, highlighting key highlights, including volume and ASP-led DOS growth, ZBM rollout to 775 doors, franchise expansion to 750 stores, and underlying PBT growth of +22%. The presentation also covers digital and e-commerce distribution, inventory management, product and merchandising, brand and marketing, and strategic commitment to customer-driven, profitable growth.

Kusumgar Ltd has reported a 102% YoY increase in revenue to ₹2,472 Mn in Q1 FY2027, driven by execution ramp-up on finished parachutes contracts. The company has also seen a significant expansion in EBITDA margin to 31.1% in Q1 FY27 from 22.0% in Q1 FY26.

Fratelli Vineyards Ltd has announced its unaudited financial results for Q1FY27, showing a 22% YoY growth in net sales, driven by strong performance in the Bottle and RTD segments. The company has maintained a healthy gross profit margin of 80% despite changes in product mix. Operating performance improved significantly, with EBITDA standing at Rs 1.1 crore, compared to a loss of Rs 2.3 crore in Q1 FY26. The company has also expanded its international footprint to 17 countries, driving higher export contribution.

Camlin Fine Sciences Limited has published un-audited financial results for the quarter ended June 30, 2026, showing a net profit of Rs. 219 crores, with a basic EPS of Rs. 0.31 and a diluted EPS of Rs. 0.31.

Bata India Ltd has submitted an investors presentation for its Q1 FY27 results, highlighting growth in retail sales, expansion of its digital channels, and improvements in inventory management.

Royal Orchid Hotels Ltd announced its Q1 FY27 performance, with a 36.1% YoY increase in income from operations, 39.1% YoY increase in EBITDA, and 11.7 CR in cash profit. The company's occupancy rate was 70.6% and ARR was ₹6,233 (+13.6% YoY). Iconiqa, a hotel operated by the company, achieved critical milestones and was rated No 1 hotel on Trip Advisor in Mumbai within 4 months of operation.

Aster DM Quality Care Ltd, a healthcare company, held its first earnings conference call for Q1 FY27, discussing its operational and financial performance. The company has unified two healthcare leaders into a single platform, with a focus on elevating clinical excellence, expanding geographic access, and driving patient-centric innovation.

Shukra Pharmaceuticals Ltd has announced its quarterly results for the period ended June 30, 2026, with a net profit of ₹1,502.98 lakhs. The company's revenue from operations was ₹2,352.23 lakhs, and its total income from operations was ₹2,406.20 lakhs. The results have been reviewed by the Audit Committee and approved by the Board of Directors.

Grasim Industries Limited has informed the Exchange about Investor Presentation for Q1FY27, presenting unaudited financial results for the quarter ended 30th June 2026, with consolidated revenue at ₹48,716 Cr. up 21% YoY, driven by strong all-round performance across its diversified businesses portfolio.

Grasim Industries Ltd presented its unaudited financial results for Q1FY27, showing a 21% YoY increase in consolidated revenue to ₹48,716 Cr, driven by strong performance across its diversified businesses. Standalone revenue reached an all-time high of ₹11,795 Cr, up 28% YoY. Consolidated EBITDA stood at ₹8,077 Cr, up 26% YoY, driven by revenue-led growth and cost efficiencies.

Royal Orchid Hotels Limited has released its Q1 FY27 investor presentation, highlighting a 36.1% year-over-year increase in consolidated income from operations and a 39.1% year-over-year increase in EBITDA.